Skip to main content

Table 2 Partial correlations analysis of variables associated with circulating SFRP5 levels in study population

From: Decreased SFRP5 correlated with excessive metabolic inflammation in polycystic ovary syndrome could be reversed by metformin: implication of its role in dysregulated metabolism

Item Plasma SFRP5 Plasma SFRP5 (age-adjusted) Plasma SFRP5
(age-BMI-adjusted)
Plasma SFRP5
(age-BMI-WHR-adjusted)
r P-value r P-value r P-value r P-value
Age(years) 0.174 0.083       
BMI (Kg/m2) -0.492  < 0.001 -0.524  < 0.001     
WHR -0.271 0.006 -0.296 0.003 0.036 0.725   
AMH (ng/ml) 0.501  < 0.001 -0.498  < 0.001 -0.284 0.005 -0.285 0.005
FAI -0.566  < 0.001 -0.560  < 0.001 -0.390  < 0.001 -0.400  < 0.001
FINS (Uiu/ml) -0.452  < 0.001 -0.464  < 0.001 -0.158 0.121 -0.161 0.114
2-h INS (Uiu/ml) -0.450  < 0.001 -0.459  < 0.001 -0.154 0.131 -0.161 0.115
FBG (mmol/l) -0.510  < 0.001 -0.568  < 0.001 -0.400  < 0.001 -0.401  < 0.001
2-hBG (mmol/l) -0.444  < 0.001 -0.484  < 0.001 -0.271 0.007 -0.274 0.007
HOMA-IR -0.484  < 0.001 -0.505  < 0.001 -0.218 0.031 -0.223 0.028
IL6(pg/ml) -0.550  < 0.001 -0.572  < 0.001 -0.463  < 0.001 -0.465  < 0.001
TNFα (ng/ml) -0.708  < 0.001 -0.707  < 0.001 -0.601  < 0.001 -0.600  < 0.001